1795 — Lotus Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- TWD56.50bn
- TWD104.70bn
- TWD20.51bn
Annual cashflow statement for Lotus Pharmaceutical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,870 | 3,940 | 5,103 | 6,360 | 5,718 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 806 | 485 | 194 | 545 | 774 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3,316 | -1,643 | -4,893 | -2,033 | -546 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 120 | 3,719 | 1,614 | 6,155 | 7,482 |
| Capital Expenditures | -1,616 | -3,069 | -3,275 | -1,466 | -4,355 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 38.9 | -1,587 | 25.7 | -1,225 | -8,113 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,577 | -4,656 | -3,249 | -2,691 | -12,468 |
| Financing Cash Flow Items | 558 | -558 | 0 | -0.312 | 1.57 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1,663 | 1,262 | 1,403 | 714 | 6,896 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 116 | 378 | -213 | 4,259 | 1,710 |